Ro vs Shed: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Shed beats Ro overall, scoring 7.8/10 vs 7.2/10. Ro is more affordable at $149/mo vs $199/mo. Choose Ro for users who want fda-approved brand-name glp-1 access includin. Choose Shed for users who want fast delivery and a streamlined compounded gl.

A side-by-side comparison of Ro and Shed covering pricing, scores, medication types, insurance, and more to help you decide.

Ro

#44 of 48

7.2/10

One of the most recognized telehealth brands, now restructured: Ro Body membership ($149/mo ongoing or $74/mo annual prepay) is priced separately from medication. Added Foundayo (Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026) alongside Wegovy, Zepbound, Ozempic, and Mounjaro.

Visit Ro

Higher Rated

Shed

#17 of 48

7.8/10

Newer GLP-1 provider focused on speed and simplicity — fast approvals, fast shipping, and a clean user experience at a competitive price point.

Visit Shed

Feature	Ro	Shed
Our Score	7.2/10	7.8/10
Starting Price	$149/mo	$199/mo
Medication Type	Brand	Both
Insurance Accepted	Yes	No
Best For	Users who want FDA-approved brand-name GLP-1 access including the new Foundayo (orforglipron) oral pill, with direct insurance billing	Users who want fast delivery and a streamlined compounded GLP-1 experience
Ranking	#44	#17

Pros & Cons Compared

Ro

Pros

+Carries Foundayo (orforglipron) — Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026 — at $149-299/mo via LillyDirect matching
+Direct insurance billing with major carriers — with coverage, Wegovy or Zepbound can cost $0-25/mo copay
+Ro Body membership: $39 first month, $149/mo ongoing, or $74/mo on annual prepay ($100/mo savings)
+Claims matched pricing with LillyDirect, NovoCare, and TrumpRx — some of the lowest cash brand prices available

Cons

−Membership and medication are billed separately — readers need to add them together for the all-in monthly cost
−Brand-name only — no compounded semaglutide or tirzepatide (compounded 'limited' footnote from prior years is not reliably offered now)
−Without insurance, brand-name meds stack on top of the $149 membership ($199+ intro, $349+ ongoing for Wegovy injection)

Shed

Pros

+Industry-leading delivery speed — most patients receive medication within 2-3 days of enrollment
+$149/mo is competitively priced for an all-inclusive compounded program with good support
+Streamlined onboarding with no video call — approved and shipped faster than most competitors
+Clean, modern UX with real-time shipping tracking and easy provider messaging

Cons

−Compounded semaglutide and tirzepatide only — no brand-name options
−Newer company (founded 2024) with limited track record and outcome data
−No insurance billing and no FSA/HSA superbills currently available
−Clinical support is responsive but less proactive than premium platforms

Our Verdict

Shed edges out Ro with a score of 7.8/10 vs 7.2/10. If budget is your priority, Ro starts at $149/mo compared to Shed's $199/mo. Ro accepts insurance, which can significantly reduce your out-of-pocket costs. Shed offers both brand-name and compounded medications, giving you more flexibility. Choose Ro if you want: users who want fda-approved brand-name glp-1 access including the new foundayo (orforglipron) oral pill, with direct insurance billing. Choose Shed if you want: users who want fast delivery and a streamlined compounded glp-1 experience.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Ro nor Shed feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review